Company Performance Metrics
AfriVax is a biotechnology contract development and manufacturing organization that focuses on vaccines, biologics, and advanced therapies. The company provides development services spanning discovery, proof-of-concept studies, product optimization, and bioinformatics using its Structural Genetics platform. AfriVax offers manufacturing services
based on its AdCEV/Egg micro-production platform, enabling recombinant protein and vaccine antigen production under GLP and GMP conditions. Its laboratory services include analytical testing, microbiology, stability studies, and batch release support for pharmaceutical and biotechnology products. The company also delivers training and consulting in quality management systems, GMP and GxP readiness, ISO standards, laboratory safety, and equipment maintenance. Through these services, AfriVax supports organizations across the product lifecycle, from early-stage research to clinical and commercial readiness.